MOST SHARED
- The 'Real' Jobless Rate: 17.5% Of Workers Are Unemployed
- Wednesday's Economic News Crunch Could Tilt Markets
- NBA D-League On The Rise
- Obama Reiterates Commitment to Boost US-India Ties
- Australia Wheat Exporters Face Challenges: GrainCorp
- Trading Block
- Stifling Anger at Work Can Kill, Survey Finds
- Japan Export Rebound Eases Fear of New Recession
- Oil Slips Below $76 On Revised US GDP Data
- Gold Hits Record on Dollar, India Buying Talk
- FDIC's Bair Cautions on Risks in Bank Break-Up Plan
- Wednesday's Economic News Crunch Could Tilt Markets
- Call Me Crazy: Confessions of a Black Friday Shopper
- US Firms Hit by Payroll Taxes at Exactly the Wrong Time
- Citi Mortgage Reveals Something the US Treasury Won't
- Fed Sanguine About US Recovery, Worried on Jobs
- MGM Pitches Sale to 20 Suitors, Including News Corp
- Holiday Guide to This Season's Smartphones
- Amended Berkshire Filing Reveals No 'Secret' Holdings
- Citi Mortgage Reveals What Treasury Won't
- S&P to Hit 1,200 by Year-End: Chief Investor
- Amended Berkshire Hathaway Filing Indicates No Secret Stock Stakes at End of Q3
- Facebook's Biggest-Ever Holiday Shopping Season
- Facebook's New Dual Class Structure - Slow Steps to an IPO
- 5 Big Bank Stocks Investors Should Consider: Strategists
- Gambling Drunk, Texting to Live And America's On Sale - Your Emails
- Nov. 24: Unusual Volume Leaders
- NBA D-League On The Rise
Text Size 
PARIS, Oct 30, 2009 (BUSINESS WIRE) -- Sanofi-aventis, one of the world's largest diversified healthcare companies, reports earnings for the third-quarter of 2009. CEO Chris Viehbacher comments on Q3 earnings, recent partnerships and acquisitions, and outlook.
Use these links to watch the video interview in the format of your choice: Windows Media Player: http://www.eurobusinessmedia.com/interviewWmp.php?id_article=486 Flash Player: http://www.eurobusinessmedia.com/interviewFlash.php?id_article=486 Use this link to read the interview transcript: http://www.eurobusinessmedia.com/transcript.php?id_article=486 Topics covered in the interview include: 1. Comments on Q3 performance 2. Topline growth drivers 3. Plavix & Eloxatin generic erosion 4. Multaq launch update 5. H1N1 vaccine update 6. 2009 EPS guidance update 7. Transforming Program 8. Merial deal update 9. Acquisition strategy 10. Ambition for 2013 About Sanofi-aventis: Sanofi-aventis, a leading global diversified healthcare company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone.
Sanofi-aventis is listed in Paris (EURONEXT : SAN) and in New York (NYSE : SNY).
Company website: http://en.sanofi-aventis.com/home.asp SOURCE: Sanofi-aventis CONTACT: Sanofi-aventis Investor Relations : IR@sanofi-aventis.com or Media Relations : MR@sanofi-aventis.com Copyright Business Wire 2009 -0- KEYWORD: France
Europe INDUSTRY KEYWORD: Health
Biotechnology
Pharmaceutical SUBJECT CODE: Webcast
Print
Email
Data is a real-time snapshot *Data is delayed at least 15 minutes